Compare ALKS & SOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | SOLS |
|---|---|---|
| Founded | 1987 | 2025 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 9.6B |
| IPO Year | 2012 | 2025 |
| Metric | ALKS | SOLS |
|---|---|---|
| Price | $43.72 | $57.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | $43.43 | ★ $79.25 |
| AVG Volume (30 Days) | 1.3M | ★ 3.0M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.28 |
| Revenue | $1,475,899,000.00 | ★ $3,886,000,000.00 |
| Revenue This Year | $24.26 | $6.36 |
| Revenue Next Year | $4.47 | $5.64 |
| P/E Ratio | ★ N/A | $46.14 |
| Revenue Growth | N/A | ★ 3.08 |
| 52 Week Low | $26.99 | $40.43 |
| 52 Week High | $55.67 | $90.80 |
| Indicator | ALKS | SOLS |
|---|---|---|
| Relative Strength Index (RSI) | 32.05 | 42.22 |
| Support Level | $36.25 | $54.88 |
| Resistance Level | $51.25 | $64.15 |
| Average True Range (ATR) | 1.39 | 2.23 |
| MACD | -0.10 | -0.25 |
| Stochastic Oscillator | 5.25 | 10.44 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.